• 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>Asthma research and practice. >Allergic rhinitis: the “Ghost Diagnosis” in patients with asthma
【24h】

Allergic rhinitis: the “Ghost Diagnosis” in patients with asthma

机译：过敏性鼻炎：哮喘患者的“鬼魂诊断”

获取原文
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

Allergic rhinitis (AR) is a common comorbidity of asthma that contributes to asthma severity. Although over 80?% of asthmatics have AR, the condition is frequently underdiagnosed in subjects with asthma. AR itself is also a highly prevalent condition, affecting 10-30?% of adults and up to 40?% of children. AR has been associated with both increased risk of asthma development and asthma severity. The exact mechanisms underlying these relationships have yet to be fully elucidated, but evidence supports a role for allergen sensitization. Compared to those with asthma alone, patients with comorbid AR and asthma have greater use of health care resources, including visits to the general practitioner, emergency department and hospitalizations. Pharmacological treatment of AR reduces this health care burden. Immunotherapy for AR improves both asthma and rhinitis symptoms in addition to preventing future allergen sensitizations and asthma development. Appropriate recognition, diagnosis and treatment of AR can significantly reduce asthma morbidity and improve quality of life
机译：变应性鼻炎（AR）是哮喘的常见合并症，可导致哮喘严重程度。尽管超过80％的哮喘患者患有AR，但哮喘患者的病情经常被误诊。 AR本身也是一种高度流行的疾病，影响了10％至30％的成年人和多达40％的儿童。 AR与哮喘发生风险增加和哮喘严重程度相关。这些关系背后的确切机制尚未完全阐明，但证据支持变应原致敏作用。与单纯哮喘患者相比，AR和哮喘合并症患者会更多地利用医疗保健资源，包括就诊全科医生，急诊科和住院治疗。 AR的药理治疗减轻了这种医疗保健负担。 AR的免疫疗法除了可以防止未来的过敏原致敏和哮喘发展外，还可以改善哮喘和鼻炎的症状。正确识别，诊断和治疗AR可显着降低哮喘的发病率并改善生活质量

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号